Editorial comment on: Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.

Biomarkers, Tumor/analysis,genetics Carcinoma/chemistry,genetics,mortality,pathology Cell Proliferation Disease-Free Survival Endothelin-1/analysis Humans Ki-67 Antigen/analysis Mutation Neoplasm Invasiveness Neoplasm Staging Prognosis Receptor, Endothelin A/analysis Receptor, Endothelin B/analysis Receptor, Fibroblast Growth Factor, Type 3/genetics Risk Assessment Risk Factors Time Factors Tumor Suppressor Protein p53/analysis Urinary Bladder Neoplasms/chemistry,genetics,mortality,pathology Urothelium/chemistry,pathology

Biomarkers, Tumor Endothelin-1 Ki-67 Antigen Receptor, Endothelin A Receptor, Endothelin B TP53 protein, human Tumor Suppressor Protein p53 FGFR3 protein, human Receptor, Fibroblast Growth Factor, Type 3